Comparative Pharmacology
Head-to-head clinical analysis: LIBRELEASE versus OXAZEPAM.
Peer-Reviewed Evidence
Head-to-head clinical analysis: LIBRELEASE versus OXAZEPAM.
LIBRELEASE vs OXAZEPAM
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
LIBRELEASE is a novel therapeutic agent that modulates neurotransmitter release by binding to presynaptic voltage-gated calcium channels, specifically the alpha-2-delta subunit, thereby reducing calcium influx and subsequent neurotransmitter exocytosis. This results in decreased neuronal excitability and modulation of pain pathways.
Binds to GABA-A receptor at benzodiazepine binding site, enhancing Cl- ion conductance and increasing inhibitory neurotransmission. Anxiolytic, sedative, hypnotic, anticonvulsant, and muscle relaxant effects.
10 mg once daily, oral, administered in the morning.
10-30 mg orally 3-4 times daily; maximum 120 mg/day.
None Documented
None Documented
Clinical Note
moderateOxazepam + Fluticasone propionate
"The risk or severity of adverse effects can be increased when Oxazepam is combined with Fluticasone propionate."
Clinical Note
moderateOxazepam + Sulfisoxazole
"The metabolism of Sulfisoxazole can be decreased when combined with Oxazepam."
Clinical Note
moderateOxazepam + Erythromycin
"The metabolism of Erythromycin can be decreased when combined with Oxazepam."
Clinical Note
moderateOxazepam + Cyclosporine
Terminal elimination half-life 12–15 hours in healthy adults; prolonged in renal impairment (up to 30 hours).
Terminal elimination half-life is 5-15 hours (mean 8 hours); no active metabolites, thus accumulation is minimal even with repeated dosing.
Primarily renal excretion of unchanged drug (60–70%) and hepatic metabolism with biliary/fecal elimination (20–30%).
Renal (primarily as glucuronide conjugates, with less than 1% unchanged); biliary/fecal excretion is minimal.
Category C
Category D/X
Benzodiazepine
Benzodiazepine
"The metabolism of Cyclosporine can be decreased when combined with Oxazepam."